Mirum Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.37 | $157.41 M | -2.5 | 51 | $0 |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $3.14 | $120.37 M | -1.65 | 384 | $380.79 M |
 APLS
|
Apellis Pharmaceuticals, Inc. | $27.52 | $4.90 B | -11.77 | 702 | $396.59 M |
 ARQT
|
Arcutis Biotherapeutics, Inc. | $10.04 | $838.13 M | -2.59 | 296 | $59.61 M |
 BPMC
|
Blueprint Medicines Corporation | $88.58 | $6.47 B | -21.48 | 638 | $249.38 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $14.10 | $1.12 B | -5.11 | 169 | $0 |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 IMCR
|
Immunocore Holdings plc | $31.11 | $2.08 B | -26.72 | 497 | $249.43 M |
 INZY
|
Inozyme Pharma, Inc. | $5.17 | $286.39 M | -3.43 | 59 | $0 |
 KALV
|
KalVista Pharmaceuticals, Inc. | $11.35 | $492.76 M | -3.74 | 150 | $0 |
 LRMR
|
Larimar Therapeutics, Inc. | $6.62 | $611.84 M | -9.99 | 42 | $0 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.24 | $19.53 M | -0.27 | 88 | $1.56 M |
 MLTX
|
MoonLake Immunotherapeutics | $55.65 | $2.62 B | -57.88 | 50 | $0 |
 TERN
|
Terns Pharmaceuticals, Inc. | $8.29 | $462.44 M | -5.67 | 66 | $0 |
 VECT
|
VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.62 | $169.62 M | -1.51 | 127 | $0 |